Containing more than 160 essays from over 40 contributors, this edited volume of essays on the science, philosophy and politics of longevity considers the project of ending aging and abolishing involuntary death-by-disease from a variety of viewpoints: scientific, technological, philosophical, pragmatic, artistic. In it you will find not only information on the ways in which science and medicine are bringing about the potential to reverse aging and defeat death within many of our own lifetimes, as well as the ways that you can increase your own longevity today in order to be there for tomorrow’s promise, but also a glimpse at the art, philosophy and politics of longevity as well – areas that will become increasingly important as we realize that advocacy, lobbying and activism can play as large a part in the hastening of progress in indefinite lifespans as science and technology can.
The collection is edited by Franco Cortese. Its contributing authors include William H. Andrews, Ph.D., Rachel Armstrong, Ph.D., Jonathan Betchtel, Yaniv Chen, Clyde DeSouza, Freija van Diujne, Ph.D., John Ellis, Ph.D., Linda Gamble, Roen Horn, the International Longevity Alliance (ILA), Zoltan Istvan, David Kekich (President & C.E.O of Maximum Life Foundation), Randal A. Koene, Ph.D., Maria Konovalenko, M.Sc. (Program Coordinator for the Science for Life Extension Foundation), Marios Kyriazis, MD, M.Sc MIBiol, CBiol (Founder of the ELPIs Foundation for Indefinite Lifespans and the medical advisor for the British Longevity Society), John R. Leonard (Director of Japan Longevity Alliance), Alex Lightman, Movement for Indefinite Life Extension (MILE), Josh Mitteldorf, Ph.D., Tom Mooney (Executive Director of the Coalition to Extend Life), Max More, Ph.D. , B.J. Murphy, Joern Pallensen, Dick Pelletier, Hank Pellissier (Founder of Brighter Brains Institute), Giulio Prisco, Marc Ransford, Jameson Rohrer, Martine Rothblatt, Ph.D., MBA, JD., Peter Rothman (editor-in-chief of H+ Magazine), Giovanni Santostasi, Ph.D (Director of Immortal Life Magazine, Eric Schulke, Jason Silva , R.U. Sirius, Ilia Stambler, Ph.D (activist at the International Longevity Alliance), G. Stolyarov II (editor-in-chief of The Rational Argumentator), Winslow Strong, Jason Sussberg, Violetta Karkucinska, David Westmorland, Peter Wicks, Ph.D, and Jason Xu (director of Longevity Party China and Longevity Party Taiwan).
Effective leaders must first learn the skill of leading themselves in order to cultivate their competencies for leading others.
Have you let your eyes wander across the management section in a bookstore or an airport newsstand recently? Chances are that your attention has been drawn to the colourful variety of easily digestible how-to-become-a-better-manager books.
In North America, books with exotic titles, such as “One Minute Manager”, “Moses CEO” and “Make It So: Management Lessons from Star Trek the Next Generation”, bring in an astronomical revenue of USD 2.4 billion every year. Most of the “voodoo” management books emphasize that you must change yourself if you want a richer and fuller life – both socially and financially.
Make no mistake
It would be easy to write off the author of books, such as “Managing Your Self” by Dr. Jagdish Parikh, as being in the same category. But, make no mistake. Dr. Parikh a professor, businessman and an author himself, has a profound knowledge of management gathered from business environments all over the world. He even found the time to co-produce the Oscar-winning movie, “Ghandi”.
“Hundreds of books and models purport to suggest the best way to become a leader. Yet many people, asked to name a leader they would consider a role model, struggle to identify even one or two individuals,” Dr. Parikh points out.
According to him, the gap between what we learn about leadership and what we actually implement exposes a fundamental flaw in most of the leadership models today. These models focus mainly on competencies required for leading an organization, but do not explain how to cultivate those core competencies. Therefore we face, in a sense, a crisis of leadership.
Conflicting values
One of Dr. Jagdish Parikh’s favorite stories is about his first day as an MBA student at Harvard Business School. Born in India, he was brought up with the belief that he had to do his utmost, whatever tasks, objectives or goals he set for himself. But, as far as the results concerned, he learned to accept them with equanimity, for such results depended on a variety of external factors and variables, over which no one could have full control. At Harvard it was a different story. During the welcoming address the dean made it clear that the MBA program was designed to ensure that there would always be more work to be done every day than the time and energy at one’s disposal.
“We were told not to feel satisfied or content with whatever we achieved, because in the moment we did so, our progress would stop along with our drive for achieving more,” says Dr. Parikh.
The message that came across to Dr. Parikh was that stress is beautiful. And if he were to progress in life, he would continue to remain dissatisfied. Going from A to B meant that C should be the next focal point, without spending time being happy about reaching B.
Cultivating consciousness
Having finished his MBA, Jagdish Parikh went back to Bombay and became successful as a businessman practicing the tenets from Harvard. However, he began to suffer negative physiological and psychological symptoms of stress after just a few years.
“I seriously began to wonder if there was another way to be successful while also remaining satisfied and happy at the same time. After deep reflection and a PhD, I discovered that the missing link between success and happiness was a lack of awareness of one’s inner dynamics,” says Dr. Parikh.
Therein lies the philosophy of Dr. Jagdish Parikh. He believes that one of the major challenges that face leaders today is to cultivate their own consciousness in a hectic business environment that doesn’t leave much time for reflection and self-discovery. However, competencies for leading others take time to grow and flourish.
“Unless one knows how to lead one’s self, it would be presumptuous for anyone to be able to lead others effectively. And, if you don’t lead your self, someone else will. The essence of leadership is to effectively manage relationships with people, events, and ideas. You can’t lead something you yourself identify with. The paradox is that detachment not withdrawal, escape, or indifference coupled with involvement not addiction – in other words, detached involvement – enables mastery. Leadership then happens to you,” Dr. Parikh underlines.
Eastern wisdom meets western science
From earlier orientations towards profit and power, up to a more recent focus on people, we are now seeing business leaders that seek alignment with global and ecological concerns. According to Dr. Parikh, this means that there is a growing interest in creating an organizational culture based on support systems, networks and shared values, rather than on power, money and personal ambition – an interest in changing outlooks through deeper insights.
“The role of management is to create within the organization a climate, a culture, and a context in which corporate enrichment and individual fulfillment collaborate and resonate progressively in the development of a creative and integrative global community,” says Dr. Parikh.
According to Dr. Parikh, leaders should have a clear stand on the fundamental issues that are facing us today, i.e. balancing “how to make a living” with “how to live” – sort of building a bridge between Western management and Eastern philosophical traditions.
“As individuals we may pursue money, power and prestige – the symbols of success – in order to be happy. But despite getting more of these we do not feel proportionately happier. After all, we’re described as human beings not human havings or even human doings. Essentially we are going up the ladder but we also have to ensure that the ladder is against the right wall. This is where a combination of Western science and Eastern wisdom would ensure a more holistic approach to leadership – and life,” says Dr. Jagdish Parikh.
Immortal Life has complied an edited volume of essays, arguments, and debates about Immortalism titled Human Destiny is to Eliminate Death from many esteemed ImmortalLife.info Authors (a good number of whom are also Lifeboat Foundation Advisory Board members as well), such as Martine Rothblatt (Ph.D, MBA, J.D.), Marios Kyriazis (MD, MS.c, MI.Biol, C.Biol.), Maria Konovalenko (M.Sc.), Mike Perry (Ph.D), Dick Pelletier, Khannea Suntzu, David Kekich (Founder & CEO of MaxLife Foundation), Hank Pellissier (Founder of Immortal Life), Eric Schulke & Franco Cortese (the previous Managing Directors of Immortal Life), Gennady Stolyarov II, Jason Xu (Director of Longevity Party China and Longevity Party Taiwan), Teresa Belcher, Joern Pallensen and more. The anthology was edited by Immortal Life Founder & Senior Editor, Hank Pellissier.
This one-of-a-kind collection features ten debates that originated at ImmortalLife.info, plus 36 articles, essays and diatribes by many of IL’s contributors, on topics from nutrition to mind-filing, from teleomeres to “Deathism”, from libertarian life-extending suggestions to religion’s role in RLE to immortalism as a human rights issue.
The book is illustrated with famous paintings on the subject of aging and death, by artists such as Goya, Picasso, Cezanne, Dali, and numerous others.
The book was designed by Wendy Stolyarov; edited by Hank Pellissier; published by the Center for Transhumanity. This edited volume is the first in a series of quarterly anthologies planned by Immortal Life
This Immortal Life Anthology includes essays, articles, rants and debates by and between some of the leading voices in Immortalism, Radical Life-Extension, Superlongevity and Anti-Aging Medicine.
A (Partial) List of the Debaters & Essay Contributors:
Martine Rothblatt Ph.D, MBA, J.D. — inventor of satellite radio, founder of Sirius XM and founder of the Terasem Movement, which promotes technological immortality. Dr. Rothblatt is the author of books on gender freedom (Apartheid of Sex, 1995), genomics (Unzipped Genes, 1997) and xenotransplantation (Your Life or Mine, 2003).
Marios Kyriazis MD, MSc, MIBiol, CBiol. founded the British Longevity Society, was the first to address the free-radical theory of aging in a formal mainstream UK medical journal, has authored dozens of books on life-extension and has discussed indefinite longevity in 700 articles, lectures and media appearances globally.
Maria Konovalenko is a molecular biophysicist and the program coordinator for the Science for Life Extension Foundation. She earned her M.Sc. degree in Molecular Biological Physics at the Moscow Institute of Physics and Technology. She is a co-founder of the International Longevity Alliance.
Jason Xu is the director of Longevity Party China and Longevity Party Taiwan, and he was an intern at SENS.
Mike Perry, PhD. has worked for Alcor since 1989 as Care Services Manager. He has authored or contributed to the automated cooldown and perfusion modeling programs. He is a regular contributor to Alcor newsletters. He has been a member of Alcor since 1984.
David A. Kekich, Founder, President & C.E.O Maximum Life Extension Foundation, works to raise funds for life-extension research. He serves as a Board Member of the American Aging Association, Life Extension Buyers’ Club and Alcor Life Extension Foundation Patient Care Trust Fund. He authored Smart, Strong and Sexy at 100?, a how-to book for extreme life extension.
Eric Schulke is the founder of the Movement for Indefinite Life Extension (MILE). He was a Director, Teams Coordinator and ran Marketing & Outreach at the Immortality Institute, now known as Longecity, for 4 years. He is the Co-Managing Director of Immortal Life.
Hank Pellissier is the Founder & Senior Editor of ImmortaLife.info. Previously, he was the founder/director of Transhumanity.net. Before that, he was Managing Director of the Institute for Ethics and Emerging Technology (ieet.org). He’s written over 120 futurist articles for IEET, Hplusmagazine.com, Transhumanity.net, ImmortalLife.info and the World Future Society.
Franco Cortese is on the Advisory Board for Lifeboat Foundation on their Scientific Advisory Board (Life-Extension Sub-Board) and their Futurism Board. He is the Co-Managing Director alongside of Immortal Life and a Staff Editor for Transhumanity. He has written over 40 futurist articles and essays for H+ Magazine, The Institute for Ethics & Emerging Technologies, Immortal Life, Transhumanity and The Rational Argumentator.
Gennady Stolyarov II is a Staff Editor for Transhumanity, Contributor to Enter Stage Right, Le Quebecois Libre, Rebirth of Reason, Ludwig von Mises Institute, Senior Writer for The Liberal Institute, and Editor-in-Chief of The Rational Argumentator.
Brandon King is Co-Director of the United States Longevity Party.
Khannea Suntzu is a transhumanist and virtual activist, and has been covered in articles in Le Monde, CGW and Forbes.
Teresa Belcher is an author, blogger, Buddhist, consultant for anti-aging, life extension, healthy life style and happiness, and owner of Anti-Aging Insights.
Dick Pelletier is a weekly columnist who writes about future science and technologies for numerous publications.
Joern Pallensen has written articles for Transhumanity and the Institute for Ethics and Emerging Technologies.
CONTENTS:
Editor’s Introduction
DEBATES
1. In The Future, With Immortality, Will There Still Be Children?
2. Will Religions promising “Heaven” just Vanish, when Immortality on Earth is attained?
3. In the Future when Humans are Immortal — what will happen to Marriage?
4. Will Immortality Change Prison Sentences? Will Execution and Life-Behind-Bars be… Too Sadistic?
5. Will Government Funding End Death, or will it be Attained by Private Investment?
6. Will “Meatbag” Bodies ever be Immortal? Is “Cyborgization” the only Logical Path?
7. When Immortality is Attained, will People be More — or Less — Interested in Sex?
8. Should Foes of Immortality be Ridiculed as “Deathists” and “Suicidalists”?
9. What’s the Best Strategy to Achieve Indefinite Life Extension?
ESSAYS
1. Maria Konovalenko:
I am an “Aging Fighter” Because Life is the Main Human Right, Demand, and Desire
2. Mike Perry:
Deconstructing Deathism — Answering Objections to Immortality
3. David A. Kekich:
How Old Are You Now?
4. David A. Kekich:
Live Long… and the World Prospers
5. David A. Kekich:
107,000,000,000 — what does this number signify?
6. Franco Cortese:
Religion vs. Radical Longevity: Belief in Heaven is the Biggest Barrier to Eternal Life?!
7. Dick Pelletier:
Stem Cells and Bioprinters Take Aim at Heart Disease, Cancer, Aging
8. Dick Pelletier:
Nanotech to Eliminate Disease, Old Age; Even Poverty
9. Dick Pelletier:
Indefinite Lifespan Possible in 20 Years, Expert Predicts
10. Dick Pelletier:
End of Aging: Life in a World where People no longer Grow Old and Die
11. Eric Schulke:
We Owe Pursuit of Indefinite Life Extension to Our Ancestors
12. Eric Schulke:
Radical Life Extension and the Spirit at the core of a Human Rights Movement
13. Eric Schulke:
MILE: Guide to the Movement for Indefinite Life Extension
14. Gennady Stolyarov II:
The Real War and Why Inter-Human Wars Are a Distraction
15. Gennady Stolyarov II:
The Breakthrough Prize in Life Sciences — turning the tide for life extension
16. Gennady Stolyarov II:
Six Libertarian Reforms to Accelerate Life Extension
17. Hank Pellissier:
Wake Up, Deathists! — You DO Want to LIVE for 10,000 Years!
18. Hank Pellissier:
Top 12 Towns for a Healthy Long Life
19. Hank Pellissier:
This list of 30 Billionaires — Which One Will End Aging and Death?
20. Hank Pellissier:
People Who Don’t Want to Live Forever are Just “Suicidal”
It may be possible one day to use effective biotechnological therapies in order to achieve extreme lifespans. In the meantime, instead of just waiting for these therapies, it may be more fruitful to live a life of constant stimulation, hyper-connection and avoidance of regularity. This is something that everybody can do today, and may have a direct impact upon radical life extension, not only for the individual but also for society.
For some time now I have been advocating the notion that exposure to meaningful information may be one way of achieving radical life extension. By meaningful information I mean anything that requires action, and not just feeding your brain with routine sets of data. Examples of this include being hyper-connected in a digital world, an enriched environment (both in the personal space and in society as a whole), a hormetic lifestyle, behavioural models such as a goal-seeking behaviour, search for excellence, and a bias for action, as well as the pursuit innovation, diversification, creativity and novelty. Most importantly, the avoidance of routine and mediocrity.
This information-rich lifestyle up-regulates the function of the brain and may have an impact upon cell immortalisation. In my latest paper (http://arxiv.org/abs/1306.2734 I provide an explanation of the exact mechanisms. I argue that the relentless exposure to useful information creates new and persisting demands for energy resources in order for this information to be assimilated by the neurons. If this process continues for some time, there will come a point where our biological mechanisms will undergo a phase transition, in effect creating a new biology. Not one based on sex and reproduction but one based on information and somatic survival.
One possible mechanism involves the immortalisation sequences of germ cells. As we know, the DNA in germ cells is essentially immortal because it is somehow able to repair age-related damage effectively. Recent research shows that some of these immortalisation mechanisms do not originate from the germ cells but from the somatic cells! In other words, our bodily cells create biological material such as error-free sequences of DNA and instead of using this themselves for their own survival, they pass it on to the germ cells to assure the survival of the species. This means that the germ-line remains immortal whereas the bodily cells eventually age and die.
The process may be forcibly changed, by overloading the system with high quality actionable information. As explained above, the assimilation of this information demands so much energy and resources from the organism that there will come a point when nature will have to make a choice: is it more economical from the thermodynamic point of view to continue the current cycle of birth, aging and death (with an immortal DNA), or is it better to downgrade this model and favour a new process of somatic survival and improved development in the same individual who would be able to live much longer? The force of evolution in a modern technological, information-laden niche may eventually favour the latter.
LongeCity has been doing advocacy and research for indefinite life extension since 2002. With the Methuselah Foundation and the M-Prize’s rise in prominence and public popularity over the past few years, it is sometimes easy to forget the smaller-scale research initiatives implemented by other organizations.
LongeCity seeks to conquer the involuntary blight of death through advocacy and research. They award small grants to promising small-scale research initiatives focused on longevity. The time to be doing this is now, with the increasing popularity and public awareness of Citizen Science growing. The 2020 H+ Conference’s theme was The Rise of the Citizen Scientist. Open –Source and Bottom-Up organization have been hallmarks of the H+ and TechProg communities for a while now, and the rise of citizen science parallels this trend.
Anyone can have a great idea, and there are many low-hanging fruits that can provide immense value and reward to the field of life extension without necessitating large-scale research initiatives, expensive and highly-trained staff or costly laboratory equipment. These low-hanging fruit can provide just as much benefit as large scale ones – and, indeed, even have the potential to provide more benefit per unit of funding than large-scale ones. They don’t call them low-hanging fruit for nothing – they are, after all, potentially quite fruitful.
In the past LongeCity has raised funding by matching donations made by the community to fund a research project that used lasers to ablate (i.e. remove) cellular lipofuscin. LongeCity raised $8,000 dollars by the community which was then matched by up to $16,000 by SENS Founation. A video describing the process can be found here. In the end they raised over $18,000 towards this research! Recall that one of Aubrey’s strategies of SENS is to remove cellular lipofuscin via genetically engineered bacteria. Another small-scale research project funded by LongeCity involved mitochondrial uncoupling in nematodes. To see more about this research success, see here.
LongeCity’s 3rd success was their project on Microglia Stem Cells in 2010. The full proposal can be found here, and more information on this second successful LongeCity research initiative can be found here.
These are real projects with real benefits that LongeCity is funding. Even if you’re not a research scientist, you can have an impact on the righteous plight to end the involuntary blight of death, by applying for a small-scale research grant from LongeCity. What have you got to lose? Really? Because it seems to me that you have just about everything to gain.
LongeCity has also contributed toward larger scale research and development initiatives in the past as well. They have sponsored projects by Alcor, SENS Foundation and Methuselah Foundation. They crowdsourced a longevity-targeted multivitamin supplement called VIMMORTAL based on bottom-up-style community suggestion and deliberation (one of the main benefits of crowdsourcing).
So? Are you interested in impacting the movement toward indefinite life extension? Then please take a look at the various types of projects listed below that LongeCity might be interested in funding.
— — — — — — — — —
The following types of projects can be supported:
• Science support: contribution to a scientific experiment that can be carried out in a short period of time with limited resources. The experiment should be distinguishable from the research that is already funded by other sources. This could be a side-experiment in an existing programme, a pilot experiment to establish feasibility, or resources for an undergrad or high-school student.
• Chapters support: organizing a local meeting with other LongeCity members or potential members. LongeCity could contribute to the room hire, the expenses of inviting a guest speaker or even the bar tab.
• Travel support: attendance at conferences, science fairs etc. where you are presenting on a topic relevant to LongeCity. Generally this will involve some promotion of the mission and/or a report on the then conference to be shared with our Members
• Grant writing:
Bring together a team of scientists and help them write a successful grant application to a public or private funding body. Depending on the project, the award will be a success premium or sometimes can cover the costs of grant preparation itself.
• Micro matching fundraiser:
If you manage to raise funds on a mission-relevant topic, LongeCity will match the funds raised. (In order to initiate one of these initiatives LongeCity usually also requires that the fundraiser spends at least 500 ‘ThankYou points’ but this requirement can be waived in specific circumstances.)
• Outreach:
Support for a specific initiative raising public awareness of the mission or of a topic relevant to our mission. This could be a local event, a specific, organized direct marketing initiative or a media feature.
• Articles:
Write a featured article for the LongeCity website on a topic of interest to our members or visitors. LongeCity is mainly looking for articles on scientific topics, but well-researched contributions on a relevant topic in policy, law, or philosophy are also welcome.
Grant Size:
‘micro grants’ — up to $180
‘small grants’ — up to $500
Grant applications exceeding $500 can be received, but will not be evaluated conclusively under the small grants scheme. Instead, LongeCity will review the application as draft and may invite a full application afterward.
Decisions as part of the small grants programme are usually pretty quick and straightforward. However please contact LongeCity with a proposal ahead of time, as they will not normally consider applications where the money has already been spent!
Proposals can be as short or elaborate as necessary, but normally should be about half a page long.
Only LongeCity Members can apply, but any Member is free to apply on behalf of someone else — thus, non-Members are welcome to find a Member to ‘sponsor’ their application.
You can also use the ideas forum to prepare the proposal. For general questions, or to discuss the proposal informally, feel free to contact LongeCity at the above email.
In this essay I argue that technologies and techniques used and developed in the fields of Synthetic Ion Channels and Ion Channel Reconstitution, which have emerged from the fields of supramolecular chemistry and bio-organic chemistry throughout the past 4 decades, can be applied towards the purpose of gradual cellular (and particularly neuronal) replacement to create a new interdisciplinary field that applies such techniques and technologies towards the goal of the indefinite functional restoration of cellular mechanisms and systems, as opposed to their current proposed use of aiding in the elucidation of cellular mechanisms and their underlying principles, and as biosensors.
In earlier essays (see here and here) I identified approaches to the synthesis of non-biological functional equivalents of neuronal components (i.e. ion-channels ion-pumps and membrane sections) and their sectional integration with the existing biological neuron — a sort of “physical” emulation if you will. It has only recently come to my attention that there is an existing field emerging from supramolecular and bio-organic chemistry centered around the design, synthesis, and incorporation/integration of both synthetic/artificial ion channels and artificial bilipid membranes (i.e. lipid bilayer). The potential uses for such channels commonly listed in the literature have nothing to do with life-extension however, and the field is to my knowledge yet to envision the use of replacing our existing neuronal components as they degrade (or before they are able to), rather seeing such uses as aiding in the elucidation of cellular operations and mechanisms and as biosensors. I argue here that the very technologies and techniques that constitute the field (Synthetic Ion-Channels & Ion-Channel/Membrane Reconstitution) can be used towards the purpose of the indefinite-longevity and life-extension through the iterative replacement of cellular constituents (particularly the components comprising our neurons – ion-channels, ion-pumps, sections of bi-lipid membrane, etc.) so as to negate the molecular degradation they would have otherwise eventually undergone.
While I envisioned an electro-mechanical-systems approach in my earlier essays, the field of Synthetic Ion-Channels from the start in the early 70’s applied a molecular approach to the problem of designing molecular systems that produce certain functions according to their chemical composition or structure. Note that this approach corresponds to (or can be categorized under) the passive-physicalist sub-approach of the physicalist-functionalist approach (the broad approach overlying all varieties of physically-embodied, “prosthetic” neuronal functional replication) identified in an earlier essay.
The field of synthetic ion channels is also referred to as ion-channel reconstitution, which designates “the solubilization of the membrane, the isolation of the channel protein from the other membrane constituents and the reintroduction of that protein into some form of artificial membrane system that facilitates the measurement of channel function,” and more broadly denotes “the [general] study of ion channel function and can be used to describe the incorporation of intact membrane vesicles, including the protein of interest, into artificial membrane systems that allow the properties of the channel to be investigated” [1]. The field has been active since the 1970s, with experimental successes in the incorporation of functioning synthetic ion channels into biological bilipid membranes and artificial membranes dissimilar in molecular composition and structure to biological analogues underlying supramolecular interactions, ion selectivity and permeability throughout the 1980’s, 1990’s and 2000’s. The relevant literature suggests that their proposed use has thus far been limited to the elucidation of ion-channel function and operation, the investigation of their functional and biophysical properties, and in lesser degree for the purpose of “in-vitro sensing devices to detect the presence of physiologically-active substances including antiseptics, antibiotics, neurotransmitters, and others” through the “… transduction of bioelectrical and biochemical events into measurable electrical signals” [2].
Thus my proposal of gradually integrating artificial ion-channels and/or artificial membrane sections for the purpse of indefinite longevity (that is, their use in replacing existing biological neurons towards the aim of gradual substrate replacement, or indeed even in the alternative use of constructing artificial neurons to, rather than replace existing biological neurons, become integrated with existing biological neural networks towards the aim of intelligence amplification and augmentation while assuming functional and experiential continuity with our existing biological nervous system) appears to be novel, while the notion of artificial ion-channels and neuronal membrane systems ion general had already been conceived (and successfully created/experimentally-verified, though presumably not integrated in-vivo).
The field of Functionally-Restorative Medicine (and the orphan sub-field of whole-brain-gradual-substrate-replacement, or “physically-embodied” brain-emulation if you like) can take advantage of the decades of experimental progress in this field, incorporating both the technological and methodological infrastructures used in and underlying the field of Ion-Channel Reconstitution and Synthetic/Artificial Ion Channels & Membrane-Systems (and the technologies and methodologies underlying their corresponding experimental-verification and incorporation techniques) for the purpose of indefinite functional restoration via the gradual and iterative replacement of neuronal components (including sections of bilipid membrane, ion channels and ion pumps) by MEMS (micro-electrocal-mechanical-systems) or more likely NEMS (nano-electro-mechanical systems).
The technological and methodological infrastructure underlying this field can be utilized for both the creation of artificial neurons and for the artificial synthesis of normative biological neurons. Much work in the field required artificially synthesizing cellular components (e.g. bilipid membranes) with structural and functional properties as similar to normative biological cells as possible, so that the alternative designs (i.e. dissimilar to the normal structural and functional modalities of biological cells or cellular components) and how they affect and elucidate cellular properties, could be effectively tested. The iterative replacement of either single neurons, or the sectional replacement of neurons with synthesized cellular components (including sections of the bi-lipid membrane, voltage-dependent ion-channels, ligand-dependent ion channels, ion pumps, etc.) is made possible by the large body of work already done in the field. Consequently the technological, methodological and experimental infrastructures developed for the fields of Synthetic
Ion-Channels and Ion-Channel/Artificial-Membrane-Reconstitution can be utilized for the purpose of a.) iterative replacement and cellular upkeep via biological analogues (or not differing significantly in structure or functional & operational modality to their normal biological counterparts) and/or b.) iterative replacement with non-biological analogues of alternate structural and/or functional modalities.
Rather than sensing when a given component degrades and then replacing it with an artificially-synthesized biological or non-biological analogue, it appears to be much more efficient to determine the projected time it takes for a given component to degrade or otherwise lose functionality, and simply automate the iterative replacement in this fashion, without providing in-vivo systems for detecting molecular or structural degradation. This would allow us to achieve both experimental and pragmatic success in such cellular-prosthesis sooner, because it doesn’t rely on the complex technological and methodological infrastructure underlying in-vivo sensing, especially on the scale of single neuron components like ion-channels, and without causing operational or functional distortion to the components being sensed.
A survey of progress in the field [3] lists several broad design motifs. I will first list the deign motifs falling within the scope of the survey, and the examples it provides. Selections from both papers are meant to show the depth and breadth of the field, rather than to elucidate the specific chemical or kinetic operations under the purview of each design-variety.
For a much more comprehensive, interactive bibliography of papers falling within the field of Synthetic Ion-Channels or constituting the historical foundations of the field, see Jon Chui’s online biography here, which charts the developments in this field up until 2011.
First Survey
Unimolecular ion channels:
Examples include a.) synthetic ion channels with oligocrown ionophores, [5] b.) using a-helical peptide scaffolds and rigid push–pull p-octiphenyl scaffolds for the recognition of polarized membranes, [6] and c.) modified varieties of the b-helical scaffold of gramicidin A [7]
Barrel-stave supramolecules:
Examples of this general class falling include avoltage-gated synthetic ion channels formed by macrocyclic bolaamphiphiles and rigidrod p-octiphenyl polyols [8].
Macrocyclic, branched and linear non-peptide bolaamphiphiles as staves:
Examples of this sub-class include synthetic ion channels formed by a.) macrocyclic, branched and linear bolaamphiphiles and dimeric steroids, [9] and by b.) non-peptide macrocycles, acyclic analogs and peptide macrocycles [respectively] containing abiotic amino acids [10].
Dimeric steroid staves:
Examples of this sub-class include channels using polydroxylated norcholentriol dimer [11].
pOligophenyls as staves in rigid rod b barrels:
Examples of this sub-class include “cylindrical self-assembly of rigid-rod b-barrel pores preorganized by the nonplanarity of p-octiphenyl staves in octapeptide-p-octiphenyl monomers” [12].
Synthetic Polymers:
Examples of this sub-class include synthetic ion channels and pores comprised of a.) polyalanine, b.) polyisocyanates, c.) polyacrylates, [13] formed by i.) ionophoric, ii.) ‘smart’ and iii.) cationic polymers [14]; d.) surface-attached poly(vinyl-n-alkylpyridinium) [15]; e.) cationic oligo-polymers [16] and f.) poly(m-phenylene ethylenes) [17].
Helical b-peptides (used as staves in barrel-stave method):
Examples of this class include: a.) cationic b-peptides with antibiotic activity, presumably acting as amphiphilic helices that form micellar pores in anionic bilayer membranes [18].
Monomeric steroids:
Examples of this sub-class falling include synthetic carriers, channels and pores formed by monomeric steroids [19], synthetic cationic steroid antibiotics [that] may act by forming micellar pores in anionic membranes [20], neutral steroids as anion carriers [21] and supramolecular ion channels [22].
Complex minimalist systems:
Examples of this sub-class falling within the scope of this survey include ‘minimalist’ amphiphiles as synthetic ion channels and pores [23], membrane-active ‘smart’ double-chain amphiphiles, expected to form ‘micellar pores’ or self-assemble into ion channels in response to acid or light [24], and double-chain amphiphiles that may form ‘micellar pores’ at the boundary between photopolymerized and host bilayer domains and representative peptide conjugates that may self assemble into supramolecular pores or exhibit antibiotic activity [25].
Non-peptide macrocycles as hoops:
Examples of this sub-class falling within the scope of this survey include synthetic ion channels formed by non-peptide macrocycles acyclic analogs [26] and peptide macrocycles containing abiotic amino acids [27].
Peptide macrocycles as hoops and staves:
Examples of this sub-class include a.) synthetic ion channels formed by self-assembly of macrocyclic peptides into genuine barrel-hoop motifs that mimic the b-helix of gramicidin A with cyclic b-sheets. The macrocycles are designed to bind on top of channels and cationic antibiotics (and several analogs) are proposed to form micellar pores in anionic membranes [28]; b.) synthetic carriers, antibiotics (and analogs) and pores (and analogs) formed by macrocyclic peptides with non-natural subunits. [Certain] macrocycles may act as b-sheets, possibly as staves of b-barrel-like pores [29]; c.) bioengineered pores as sensors. Covalent capturing and fragmentations [have been] observed on the single-molecule level within engineered a-hemolysin pore containing an internal reactive thiol [30].
Summary
Thus even without knowledge of supramolecular or organic chemistry, one can see that a variety of alternate approaches to the creation of synthetic ion channels, and several sub-approaches within each larger ‘design motif’ or broad-approach, not only exist but have been experimentally verified, varietized and refined.
Second Survey
The following selections [31] illustrate the chemical, structural and functional varieties of synthetic ions categorized according to whether they are cation-conducting or anion-conducting, respectively. These examples are used to further emphasize the extent of the field, and the number of alternative approaches to synthetic ion-channel design, implementation, integration and experimental-verification already existent. Permission to use all the following selections and figures were obtained from the author of the source.
There are 6 classical design-motifs for synthetic ion-channels, categorized by structure, that are identified within the paper:
“The first non-peptidic artificial ion channel was reported by Kobuke et al. in 1992” [33].
“The channel contained “an amphiphilic ion pair consisting of oligoether-carboxylates and mono- (or di-) octadecylammoniumcations. The carboxylates formed the channel core and the cations formed the hydrophobic outer wall, which was embedded in the bilipid membrane with a channel length of about 24 to 30 Å. The resultant ion channel, formed from molecular self-assembly, is cation selective and voltage-dependent” [34].
“Later, Kokube et al. synthesized another channel comprising of resorcinol based cyclic tetramer as the building block. The resorcin-[4]-arenemonomer consisted of four long alkyl chains which aggregated to forma dimeric supramolecular structure resembling that of Gramicidin A” [35]. “Gokel et al. had studied [a set of] simple yet fully functional ion channels known as “hydraphiles” [39].
“An example (channel 3) is shown in Figure 1.6, consisting of diaza-18-crown-6 crown ether groups and alkyl chain as side arms and spacers. Channel 3 is capable of transporting protons across the bilayer membrane” [40].
“A covalently bonded macrotetracycle4 (Figure 1.8) had shown to be about three times more active than Gokel’s ‘hydraphile’ channel, and its amide-containing analogue also showed enhanced activity” [44].
“Inorganic derivative using crown ethers have also been synthesized. Hall et. al synthesized an ion channel consisting of a ferrocene and 4 diaza-18-crown-6 linked by 2 dodecyl chains (Figure 1.9). The ion channel was redox-active as oxidation of the ferrocene caused the compound to switch to an inactive form” [45]
B STAVES:
“These are more difficult to synthesize [in comparison to unimolecular varieties] because the channel formation usually involves self-assembly via non-covalent interactions” [47].“A cyclic peptide composed of even number of alternating D- and L-amino acids (Figure 1.10) was suggested to form barrel-hoop structure through backbone-backbone hydrogen bonds by De Santis” [49].
“A tubular nanotube synthesized by Ghadiri et al. consisting of cyclic D and L peptide subunits form a flat, ring-shaped conformation that stack through an extensive anti-parallel β-sheet-like hydrogen bonding interaction (Figure 1.11)” [51].
“Experimental results have shown that the channel can transport sodium and potassium ions. The channel can also be constructed by the use of direct covalent bonding between the sheets so as to increase the thermodynamic and kinetic stability” [52].
“By attaching peptides to the octiphenyl scaffold, a β-barrel can be formed via self-assembly through the formation of β-sheet structures between the peptide chains (Figure 1.13)” [53].
“The same scaffold was used by Matile etal. to mimic the structure of macrolide antibiotic amphotericin B. The channel synthesized was shown to transport cations across the membrane” [54].
“Attaching the electron-poor naphthalenediimide (NDIs) to the same octiphenyl scaffold led to the hoop-stave mismatch during self-assembly that results in a twisted and closed channel conformation (Figure 1.14). Adding the compleentary dialkoxynaphthalene (DAN) donor led to the cooperative interactions between NDI and DAN that favors the formation of barrel-stave ion channel.” [57].
MICELLAR
“These aggregate channels are formed by amphotericin involving both sterols and antibiotics arranged in two half-channel sections within the membrane” [58].
“An active form of the compound is the bolaamphiphiles (two-headed amphiphiles). (Figure 1.15) shows an example that forms an active channel structure through dimerization or trimerization within the bilayer membrane. Electrochemical studies had shown that the monomer is inactive and the active form involves dimer or larger aggregates” [60].
ANION CONDUCTING CHANNELS:
“A highly active, anion selective, monomeric cyclodextrin-based ion channel was designed by Madhavan et al (Figure 1.16). Oligoether chains were attached to the primary face of the β-cyclodextrin head group via amide bonds. The hydrophobic oligoether chains were chosen because they are long enough to span the entire lipid bilayer. The channel was able to select “anions over cations” and “discriminate among halide anions in the order I-> Br-> Cl- (following Hofmeister series)” [61].
“The anion selectivity occurred via the ring of ammonium cations being positioned just beside the cyclodextrin head group, which helped to facilitate anion selectivity. Iodide ions were transported the fastest because the activation barrier to enter the hydrophobic channel core is lower for I- compared to either Br- or Cl-“ [62]. “A more specific artificial anion selective ion channel was the chloride selective ion channel synthesized by Gokel. The building block involved a heptapeptide with Proline incorporated (Figure 1.17)” [63].
Cellular Prosthesis: Inklings of a New Interdisciplinary Approach
The paper cites “nanoreactors for catalysis and chemical or biological sensors” and “interdisciplinary uses as nano –filtration membrane, drug or gene delivery vehicles/transporters as well as channel-based antibiotics that may kill bacterial cells preferentially over mammalian cells” as some of the main applications of synthetic ion-channels [65], other than their normative use in elucidating cellular function and operation.
However, I argue that a whole interdisciplinary field and heretofore-unrecognized new approach or sub-field of Functionally-Restorative Medicine is possible through taking the technologies and techniques involved in in constructing, integrating, and experimentally-verifying either a.) non-biological analogues of ion-channels & ion-pumps (thus trans-membrane membrane proteins in general, also sometimes referred to as transport proteins or integral membrane proteins) and membranes (which include normative bilipid membranes, non-lipid membranes and chemically-augmented bilipid membranes), and b.) the artificial synthesis of biological analogues of ion-channels, ion-pumps and membranes, which are structurally and chemically equivalent to naturally-occurring biological components but which are synthesized artificially – and applying such technologies and techniques toward the purpose the gradual replacement of our existing biological neurons constituting our nervous systems – or at least those neuron-populations that comprise the neo- and prefrontal-cortex, and through iterative procedures of gradual replacement thereby achieving indefinite-longevity. There is still work to be done in determining the comparative advantages and disadvantages of various structural and functional (i.e. design) motifs, and in the logistics of implanting the iterative replacement or reconstitution of ion-channels, ion-pumps and sections of neuronal membrane in-vivo.
The conceptual schemes outlined in Concepts for Functional Replication of Biological Neurons [66], Gradual Neuron Replacement for the Preservation of Subjective-Continuity [67] and Wireless Synapses, Artificial Plasticity, and Neuromodulation [68] would constitute variations on the basic approach underlying this proposed, embryonic interdisciplinary field. Certain approaches within the fields of nanomedicine itself, particularly those approaches that constitute the functional emulation of existing cell-types, such as but not limited to Robert Freitas’s conceptual designs for the functional emulation of the red blood cell (a.k.a. erythrocytes, haematids) [69], i.e. the Resperocyte, itself should be seen as falling under the purview of this new approach, although not all approaches to Nanomedicine (diagnostics, drug-delivery and neuroelectronic interfacing) constitute the physical (i.e. electromechanical, kinetic and/or molecular physically-embodied) and functional emulation of biological cells.
The field of functionally-restorative medicine in general (and of nanomedicine in particular) and the field of supramolecular and organic chemistry converge here, where these technological, methodological, and experimental infrastructures developed in field of Synthetic Ion-Channels and Ion Channel Reconstitution can be employed to develop a new interdisciplinary approach that applies the logic of prosthesis to the cellular and cellular-component (i.e. sub-cellular) scale; same tools, new use. These techniques could be used to iteratively replace the components of our neurons as they degrade, or to replace them with more robust systems that are less susceptible to molecular degradation. Instead of repairing the cellular DNA, RNA and protein transcription and synthesis machinery, we bypass it completely by configuring and integrating the neuronal components (ion-channels, ion-pumps and sections of bilipid membrane) directly.
Thus I suggest that theoreticians of nanomedicine look to the large quantity of literature already developed in the emerging fields of synthetic ion-channels and membrane-reconstitution, towards the objective of adapting and applying existing technologies and methodologies to the new purpose of iterative maintenance, upkeep and/or replacement of cellular (and particularly neuronal) constituents with either non-biological analogues or artificially-synthesized-but-chemically/structurally-equivalent biological analogues.
This new sub-field of Synthetic Biology needs a name to differentiate it from the other approaches to Functionally-Restorative Medicine. I suggest the designation ‘cellular prosthesis’.
References:
[1] Williams (1994)., An introduction to the methods available for ion channel reconstitution. in D.C Ogden Microelectrode techniques, The Plymouth workshop edition, CambridgeCompany of Biologists.
[2] Tomich, J., Montal, M. (1996). U.S Patent No. 5,16,890. Washington, DC: U.S. Patent and Trademark Office.
[69] Freitas Jr., R., (1998). “Exploratory Design in Medical Nanotechnology: A Mechanical Artificial Red Cell”. Artificial Cells, Blood Substitutes, and Immobil. Biotech. (26): 411–430. Access: http://www.ncbi.nlm.nih.gov/pubmed/9663339
UPDATE: A generous contribution of $5,000 from the Methuselah Foundation has been received! This will put the fundraiser over the top of the cost and pay for the advanced Champions Oncology treatment described below.
However, Dr. Coles still has other medical expenses outstanding, and more will be coming in.
To cover these as well as Dr. Coles’s many other personal expenses, the fundraiser will now have an extended timeframe and the limit has been raised to $20,000.
We are currently at $13,385 of our 20,000 goal! Help us make it all the way!
Your contribution would help Dr. Coles continue his contributions and be greatly appreciated.
*** PLEASE alert your friends. L Stephen Coles spend his entire professional career trying to save your life; take a second to help save his.***
Stephen Coles is one of the heroes of our time, who has contributed immensely to the prospects for longevity for all of us. I am honored to be able to assist him in his own struggle against a life-threatening illness, so that he could have decades and centuries more to fight the most dangerous, the most destructive enemies of senescence and death.Anonymous
Anonymous
donated$50.00
Tuesday, June 04, 2013
marshall zablen
donated$300.00
Tuesday, June 04, 2013
Anonymous
donated$200.00
Tuesday, June 04, 2013
Anonymous
donated$200.00
Tuesday, June 04, 2013
Björn Kleinert
donated$50.00
Tuesday, June 04, 2013
Get well !
Joao Pedro Magalhaes
donated $50.00
Tuesday, June 04, 2013
Anonymous
donated Hidden Amount
Monday, June 03, 2013
Otto
donated $20.00
Monday, June 03, 2013
Anonymous
donated $20.00
Monday, June 03, 2013
Franco Cortese
donated $100.00
Monday, June 03, 2013
PLEASE donate ANYTHING you can to help save the life of L. Stephen Coles, who has spent his entire professional career trying to save yours!
prayers are on the way for more than 65% of deaths. Aging is a cause of adult cancer, stroke and many others age related diseases. Researchers fighting aging are the best people, they are fighting for all of us. Let’s pay them back!
Bijan Pourat MD
donated$250.00
Saturday, June 01, 2013
Maxim Kholin
donated Hidden Amount
Saturday, June 01, 2013
Aging is a disease. Aging is responsible
Anonymous
donated $60.00
Saturday, June 01, 2013
Nils Alexander Hizukuri
donated $30.00
Saturday, June 01, 2013
All the best!
Anonymous
donated$40.00
Saturday, June 01, 2013
Danny Bobrow
donated Hidden Amount
Saturday, June 01, 2013
Steve, win this fight for us all. I send you healing thoughts.
Danny
Steve, friends and family, but it is an outstanding, real-world example of the advancing frontier of science and medicine. The entire life-extension community should rally in support of this effort for Steve and for the acquisition of important scientific knowledge.
Cliff Hague
donated $100.00
Saturday, June 01, 2013
Best wishes for a speedy recovery.
Tom Coote
donated $100.00
Friday, May 31, 2013
With Best Wishes!
Anonymous
donated $100.00
Friday, May 31, 2013
Allen Taylor
donated$25.00
Friday, May 31, 2013
Gunther Kletetschka
donated Hidden Amount
Friday, May 31, 2013
john mccormack, Australia
donated $50.00
Friday, May 31, 2013
phil kernan
donated $100.00
Friday, May 31, 2013
Gary and Marie Livick
donated $100.00
Friday, May 31, 2013
ingeseim
donated Hidden Amount
Friday, May 31, 2013
TeloMe Inc.
donated $100.00
Friday, May 31, 2013
Not only is this an important cause for
-Preston Estep, Ph.D.
CEO and Chief Scientific Officer, TeloMe, Inc.
Not only is this an important cause for Steve, friends and family, but it is an outstanding, real-world example of the advancing frontier of science and medicine. The entire life-extension community should rally in support of this effort for Steve and for the acquisition of important scientific knowledge. –Preston Estep, Ph.D. CEO and Chief Scientific Officer, TeloMe, Inc.
*** PLEASE alert your friends—Our own continued health and longevity may depend on Steve continuing his work.***
This call for support was also posted by Ilia Stambler on the Longevity Alliance Website, and organized on YouCaring.com by John M. Adams. Eric Schulke has also helped tremendously in spreading the word about the Fundraiser.
Since founding the Los Angeles Gerontology Research Group in 1990, Dr. L. Stephen Coles M.D., Ph.D., has worked tirelessly to develop new ways to slow and ultimately reverse human aging.
Everyone active in the LA-GRG or the Worldwide GRG Discussion Group have benefited from his expertise. His continual reporting of news about the latest developments to the List and his work in areas such as gathering blood samples for a complete genome analysis of the oldest people in the world (supercentenarians, aged 110+) is ground breaking and far ahead of anything that has ever been accomplished before. Publication of this work is expected in collaboration with Stanford University before the end of the year. Other accomplishments are equally notable
BRIEF summary of his work: L. Stephen Coles, M.D. Ph.D — Cited in more than 250 scientific articles — Profiled as notable person in Wikipedia — Many other contributions to aging research and advancing long, healthy life
Steve Coles was diagnosed with Adenocarcinoma (Pancreatic Cancer) at the head of the pancreas on Christmas Eve of last year. Pancreatic cancer is particularly insidious. He underwent a Whipple (Surgical) Procedure on January 3rd that produced a beneficial result. The tumor’s complete obstruction to the common bile duct that had caused jaundice and severe pruritus (skin itching leading to scratching to the point of bleeding) was almost immediately reversed in two days. His subsequent chemotherapy with Gemzar over the past three months will hopefully prevent metastases from spreading to other organs. But we won’t know his prognosis until June 7th when a CT Scan will be compared with a baseline scan performed before the start of chemo interpreted by a cancer radiologist.
We now have the opportunity to carry out a personalized chemo treatment regimen created by a start-up company called Champions Oncology in Baltimore, MD; USA affiliated with the Johns Hopkins School of Medicine. Champions is a world class organization that will analyze the tissue sample that has already been sent to them. Then, a custom treatment program will be prescribed for Steve based on a mouse model, since each tumor is unique and pure test tube trials have not been shown to be effective.
Champions Oncology’s service is to test in mice what can work for Dr. Coles. This is done through two steps:
(1) To implant Dr. Coles’s cancer on mice. (This part has been successfully carried out, and it will allow us to test nine different treatment protocols on Dr. Coles’s specific tumor tissue in mice).
(2) Test the treatments on the mice (The treatments have been defined with Dr. James P. Watson, Dr. Coles, and his oncologists.)
Dr. Joao Pedro de Magalhes of Liverpool, UK was the first to propose employing the services of Champions Oncology. They have a good track record. The biggest risk is that the process normally takes so long that the patient dies before the results can be obtained (especially with such an aggressive, malignant cancer, as Dr. Coles’s). Luckily, this part went right. Also, there is a risk is that Step-1 won’t work. Luckily for us, this part went right, too. Therefore, so far, it seems that choosing Champions Oncology’s approach was the right choice. We can’t be sure that Step-2 will be as successful, but we need to try.
In addition to his medical team here in the U.S., our international friends have been active on his behalf. They successfully negotiated a 60 percent reduction in cost.
NOW, YOU CAN HELP IN TWO WAYS:
(1) CONTRIBUTE TO THIS FUND
Time is of the essence. The good people at Champions Oncology have agreed to begin the analysis immediately.
Steve Coles needs your support.
It may make THE difference. Please dig deep and support him by contributing to the fund.
*** Our own continued health and longevity may depend on Steve continuing his work.***
(2) SEND REFERRALS TO CHAMPIONS ONCOLOGY
Champions Oncology is an early-stage for-profit company. Champions is not a philanthropy. Like many companies offering breakthrough technologies, it has light bills to pay, payroll to make on time, and many other typical expenses.
Please think of any oncologists how may refer patients to Champions, then contact any of the individuals listed below so we may get life-saving information about Champions into their hands. Champions is particularly well set up to accommodate physicians and patients in the Eastern U.S., Germany, France, Brazil, and Japan.
We wish to acknowledge the GRG (the Gerontology Research Group—A discussion group of ~400 members worldwide.
prayers are on the way for more than 65% of deaths. Aging is a cause of adult cancer, stroke and many others age related diseases. Researchers fighting aging are the best people, they are fighting for all of us. Let’s pay them back!
Bijan Pourat MD
donated$250.00
Saturday, June 01, 2013
Maxim Kholin
donated Hidden Amount
Saturday, June 01, 2013
Aging is a disease. Aging is responsible
Anonymous
donated$60.00
Saturday, June 01, 2013
Nils Alexander Hizukuri
donated$30.00
Saturday, June 01, 2013
All the best!
Anonymous
donated$40.00
Saturday, June 01, 2013
Danny Bobrow
donated Hidden Amount
Saturday, June 01, 2013
Steve, win this fight for us all. I send you healing thoughts.
Danny Steve, friends and family, but it is an outstanding, real-world example of the advancing frontier of science and medicine. The entire life-extension community should rally in support of this effort for Steve and for the acquisition of important scientific knowledge.
In rich countries, more than 80% of the population today will survive past the age of 70. About 150 years ago, only 20% did. In all this while, though, only one person lived beyond the age of 120. This has led experts to believe that there may be a limit to how long humans can live.
Animals display an astounding variety of maximum lifespan ranging from mayflies and gastrotrichs, which live for 2 to 3 days, to giant tortoises and bowhead whales, which can live to 200 years. The record for the longest living animal belongs to the quahog clam, which can live for more than 400 years.
If we look beyond the animal kingdom, among plants the giant sequoia lives past 3000 years, and bristlecone pines reach 5000 years. The record for the longest living plant belongs to the Mediterranean tapeweed, which has been found in a flourishing colony estimated at 100,000 years old.
Some animals like the hydra and a species of jellyfish may have found ways to cheat death, but further research is needed to validate this.
The natural laws of physics may dictate that most things must die. But that does not mean we cannot use nature’s templates to extend healthy human lifespan beyond 120 years.
Putting a lid on the can
Gerontologist Leonard Hayflick at the University of California thinks that humans have a definite expiry date. In 1961, he showed that human skin cells grown under laboratory conditions tend to divide approximately 50 times before becoming senescent, which means no longer able to divide. This phenomenon that any cell can multiply only a limited number of times is called the Hayflick limit.
Since then, Hayflick and others have successfully documented the Hayflick limits of cells from animals with varied life spans, including the long-lived Galapagos turtle (200 years) and the relatively short-lived laboratory mouse (3 years). The cells of a Galapagos turtle divide approximately 110 times before senescing, whereas mice cells become senescent within 15 divisions.
The Hayflick limit gained more support when Elizabeth Blackburn and colleagues discovered the ticking clock of the cell in the form of telomeres. Telomeres are repetitive DNA sequence at the end of chromosomes which protects the chromosomes from degrading. With every cell division, it seemed these telomeres get shorter. The result of each shortening was that these cells were more likely to become senescent.
Other scientists used census data and complex modelling methods to come to the same conclusion: that maximum human lifespan may be around 120 years. But no one has yet determined whether we can change the human Hayflick limit to become more like long-lived organisms such as the bowhead whales or the giant tortoise.
What gives more hope is that no one has actually proved that the Hayflick limit actually limits the lifespan of an organism. Correlation is not causation. For instance, despite having a very small Hayflick limit, mouse cells typically divide indefinitely when grown in standard laboratory conditions. They behave as if they have no Hayflick limit at all when grown in the concentration of oxygen that they experience in the living animal (3–5% versus 20%). They make enough telomerase, an enzyme that replaces degraded telomeres with new ones. So it might be that currently the Hayflick “limit” is more a the Hayflick “clock”, giving readout of the age of the cell rather than driving the cell to death.
The trouble with limits
The Hayflick limit may represent an organism’s maximal lifespan, but what is it that actually kills us in the end? To test the Hayflick limit’s ability to predict our mortality we can take cell samples from young and old people and grow them in the lab. If the Hayflick limit is the culprit, a 60-year-old person’s cells should divide far fewer times than a 20-year-old’s cells.
But this experiment fails time after time. The 60-year-old’s skin cells still divide approximately 50 times – just as many as the young person’s cells. But what about the telomeres: aren’t they the inbuilt biological clock? Well, it’s complicated.
When cells are grown in a lab their telomeres do indeed shorten with every cell division and can be used to find the cell’s “expiry date”. Unfortunately, this does not seem to relate to actual health of the cells.
It is true that as we get older our telomeres shorten, but only for certain cells and only during certain time. Most importantly, trusty lab mice have telomeres that are five times longer than ours but their lives are 40 times shorter. That is why the relationship between telomere length and lifespan is unclear.
Apparently using the Hayflick limit and telomere length to judge maximum human lifespan is akin to understanding the demise of the Roman empire by studying the material properties of the Colosseum. Rome did not fall because the Colosseum degraded; quite the opposite in fact, the Colosseum degraded because the Roman Empire fell.
Within the human body, most cells do not simply senesce. They are repaired, cleaned or replaced by stem cells. Your skin degrades as you age because your body cannot carry out its normal functions of repair and regeneration.
To infinity and beyond
If we could maintain our body’s ability to repair and regenerate itself, could we substantially increase our lifespans? This question is, unfortunately, vastly under-researched for us to be able to answer confidently. Most institutes on ageing promote research that delays onset of the diseases of ageing and not research that targets human life extension.
Those that look at extension study how diets like calorie restriction affect human health or the health impacts of molecules like resveratrol derived from red wine. Other research tries to understand the mechanisms underlying the beneficial effects of certain diets and foods with hopes of synthesising drugs that do the same. The tacit understanding in the field of gerontology seems to be that, if we can keep a person healthy longer, we may be able to modestly improve lifespan.
Living long and having good health are not mutually exclusive. On the contrary, you cannot have a long life without good health. Currently most ageing research is concentrated on improving “health”, not lifespan. If we are going to live substantially longer, we need to engineer our way out of the current 120-year-barrier.
Avi Roy does not work for, consult to, own shares in or receive funding from any company or organisation that would benefit from this article, and has no relevant affiliations.
The following article was originally published by Immortal Life
When asked what the biggest bottleneck for Radical or Indefinite Longevity is, most thinkers say funding. Some say the biggest bottleneck is breakthroughs and others say it’s our way of approaching the problem (i.e. that we’re seeking healthy life extension whereas we should be seeking more comprehensive methods of indefinite life-extension), but the majority seem to feel that what is really needed is adequate funding to plug away at developing and experimentally-verifying the various, sometimes mutually-exclusive technologies and methodologies that have already been proposed. I claim that Radical Longevity’s biggest bottleneck is not funding, but advocacy.
This is because the final objective of increased funding for Radical Longevity and Life Extension research can be more effectively and efficiently achieved through public advocacy for Radical Life Extension than it can by direct funding or direct research, per unit of time or effort. Research and development obviously still need to be done, but an increase in researchers needs an increase in funding, and an increase in funding needs an increase in the public perception of RLE’s feasibility and desirability.
There is no definitive timespan that it will take to achieve indefinitely-extended life. How long it takes to achieve Radical Longevity is determined by how hard we work at it and how much effort we put into it. More effort means that it will be achieved sooner. And by and large, an increase in effort can be best achieved by an increase in funding, and an increase in funding can be best achieved by an increase in public advocacy. You will likely accelerate the development of Indefinitely-Extended Life, per unit of time or effort, by advocating the desirability, ethicacy and technical feasibility of longer life than you will by doing direct research, or by working towards the objective of directly contributing funds to RLE projects and research initiatives. Continue reading “Longevity’s Bottleneck May Be Funding, But Funding’s Bottleneck is Advocacy & Activism” | >